Phase Iii Trial Evaluating The Addition Of Bevacizumab To Endocrine Therapy As First-Line Treatment For Advanced Breast Cancer: The Lea Study.

CANCER RESEARCH(2011)

引用 0|浏览26
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要